Proteus Biomedical, best known here for ‘chip pills’ that monitor medication compliance (13 January, 9 February, more), just received FDA 510(k) approval for their Raisin Personal Monitor, 
a wearable device for remote recording and analysis of heart rate, physical activity, body position (interesting) and patient-logged events (even more interesting). This physiologic monitor (photo left) adheres to skin and communicates information via Bluetooth to any computerized device, such as a mobile phone (iPhone at right.) The release calls it part of an “integrated intelligent medicine system to link sensor-based formulations of pharmaceutical products to individualized physiologic response and outcomes-based treatment systems.” (Whew.) And modestly buried in the release is the completion of $25 million in Series E financing from existing investors (Medtronic), and new ones Novartis and ON Semiconductor. Business Wire release.